vs
CARTERS INC（CRI）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是CARTERS INC的1.9倍（$1.4B vs $757.8M），瑞思迈净利率更高（27.6% vs 1.5%，领先26.1%），瑞思迈同比增速更快（11.0% vs -0.1%），瑞思迈自由现金流更多（$311.2M vs $-144.1M）
卡特公司是美国知名儿童服饰设计与销售龙头企业，由威廉·卡特于1865年创立，主打婴童服饰品类，凭借多年的行业深耕，在北美儿童服饰市场拥有较高的认可度与市场份额。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CRI vs RMD — 直观对比
营收规模更大
RMD
是对方的1.9倍
$757.8M
营收增速更快
RMD
高出11.1%
-0.1%
净利率更高
RMD
高出26.1%
1.5%
自由现金流更多
RMD
多$455.3M
$-144.1M
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $757.8M | $1.4B |
| 净利润 | $11.6M | $392.6M |
| 毛利率 | 45.1% | 61.8% |
| 营业利润率 | 3.8% | 34.6% |
| 净利率 | 1.5% | 27.6% |
| 营收同比 | -0.1% | 11.0% |
| 净利润同比 | -80.1% | 13.9% |
| 每股收益（稀释后） | $0.32 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRIRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $757.8M | $1.3B | ||
| Q2 25 | $585.3M | $1.3B | ||
| Q1 25 | $629.8M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润CRIRMD
| Q4 25 | — | $392.6M | ||
| Q3 25 | $11.6M | $348.5M | ||
| Q2 25 | $446.0K | $379.7M | ||
| Q1 25 | $15.5M | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | — | $311.4M | ||
| Q2 24 | — | $292.2M | ||
| Q1 24 | — | $300.5M |
毛利率CRIRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | 45.1% | 61.5% | ||
| Q2 25 | 48.1% | 60.8% | ||
| Q1 25 | 46.2% | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率CRIRMD
| Q4 25 | — | 34.6% | ||
| Q3 25 | 3.8% | 33.4% | ||
| Q2 25 | 0.7% | 33.7% | ||
| Q1 25 | 4.1% | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率CRIRMD
| Q4 25 | — | 27.6% | ||
| Q3 25 | 1.5% | 26.1% | ||
| Q2 25 | 0.1% | 28.2% | ||
| Q1 25 | 2.5% | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 23.9% | ||
| Q1 24 | — | 25.1% |
每股收益（稀释后）CRIRMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.32 | $2.37 | ||
| Q2 25 | $0.01 | $2.58 | ||
| Q1 25 | $0.43 | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | — | $2.11 | ||
| Q2 24 | — | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.2M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $864.6M | $6.3B |
| 总资产 | $2.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CRIRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $184.2M | $1.4B | ||
| Q2 25 | $338.2M | $1.2B | ||
| Q1 25 | $320.8M | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务CRIRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益CRIRMD
| Q4 25 | — | $6.3B | ||
| Q3 25 | $864.6M | $6.1B | ||
| Q2 25 | $853.9M | $6.0B | ||
| Q1 25 | $847.2M | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产CRIRMD
| Q4 25 | — | $8.5B | ||
| Q3 25 | $2.5B | $8.3B | ||
| Q2 25 | $2.5B | $8.2B | ||
| Q1 25 | $2.3B | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $6.8B |
负债/权益比CRIRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-128.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-144.1M | $311.2M |
| 自由现金流率自由现金流/营收 | -19.0% | 21.9% |
| 资本支出强度资本支出/营收 | 2.1% | 2.0% |
| 现金转化率经营现金流/净利润 | -11.04× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流CRIRMD
| Q4 25 | — | $339.7M | ||
| Q3 25 | $-128.0M | $457.3M | ||
| Q2 25 | $40.3M | $538.8M | ||
| Q1 25 | $-48.6M | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | — | $325.5M | ||
| Q2 24 | — | $440.1M | ||
| Q1 24 | — | $402.0M |
自由现金流CRIRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | $-144.1M | $414.4M | ||
| Q2 25 | $24.1M | $508.2M | ||
| Q1 25 | $-59.0M | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率CRIRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | -19.0% | 31.0% | ||
| Q2 25 | 4.1% | 37.7% | ||
| Q1 25 | -9.4% | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度CRIRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | 2.1% | 3.2% | ||
| Q2 25 | 2.8% | 2.3% | ||
| Q1 25 | 1.6% | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率CRIRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | -11.04× | 1.31× | ||
| Q2 25 | 90.37× | 1.42× | ||
| Q1 25 | -3.13× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
